Study on the Antibody Level Against SARS-CoV-2 (COVID-19)in Dazhu County in 2023

NCT05758675 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2023-03-08

No results posted yet for this study

Summary

About 15,000 to 25,000 subjects will be screened. Their information will be collected, venous blood will be sampled, their serum antibody levels will be detected, and the incidence of COVID-19 wil be followed up.

Conditions

Sponsors & Collaborators

  • Sinocelltech Ltd.

    lead INDUSTRY

Principal Investigators

  • Bo Zhou, M.D. · Dazhu County Center for Disease Control and Prevention

Eligibility

Min Age
3 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-21
Primary Completion
2023-09-08
Completion
2023-12-08

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05758675 on ClinicalTrials.gov